A lawsuit against the genomics company "imposes top-down restrictions" rather than "establishing clear rules" or "letting ...

Anne Wojcicki, co-founder and former CEO of 23andMe, will regain control of the embattled genetic testing company through a ...

Anne Wojcicki, co-founder and former CEO of 23andMe, has bid to buy back the genetic testing platform, which was pronounced ...

UBS has decided Regeneron Pharmaceuticals needs a new wardrobe, trimming its price target from $633 to a more modest $560.

Westlake and Ascend close plants, Chemify opens AI-robotics lab, Formation licenses gusacitinib to Sanofi, and more ...

Japan’s Nippon Steel has completed its purchase of U.S. Steel after reaching a national-security agreement with the White ...

23andMe looked set to be acquired by biopharma group Regeneron after a $256 million takeover deal was agreed last month, but Wojcicki now says she wants to table a new offer backed by "a Fortune ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. UBS has ...

Anne Wojcicki, founder of 23andMe, has successfully repurchased the genetic testing firm out of bankruptcy through her ...

ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced that it has received an extension of 180 calendar ...

More reports of Kroger-owned locations closing across the country are appearing after the company said it will be shuttering 60 stores.

Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million Global News Select May 19, 2025, 11:55:00 AM. Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for $256 ...